牛乳腺炎市場：依類型、產品、給藥途徑、治療方法、最終用戶和地區規模、佔有率、展望和機會分析，2025年～2032年

2025年全球牛乳腺炎市場規模估計為 15.646億美元，預計到2032年將達到 22.609億美元，2025-2032年的年複合成長率（CAGR）為 5.4%。

圖表.牛乳腺炎市場佔有率（%），依地區（2025年）

牛乳腺炎的特徵是由於物理創傷或微生物引起的疾病導致乳腺組織出現長期發炎反應。這是一種危及生命的乳房感染疾病，在世界各地的乳牛中最為常見。這種情況已知會損害乳製品產業的利潤率。乳腺炎是由大量不同的微生物種類引起的。其中包括病毒、黴漿菌、真菌和細菌。乳腺炎表現為乳房內出現紅色硬塊。增大的乳腺會高熱，觸摸會造成動物疼痛和不適。為了避免被擠奶，動物不會碰觸或踢乳房。在這種情況下，常見症狀是血栓、惡臭的褐色分泌物和奶栓。

當動物體溫升高時，乳汁分泌就會停止或受到嚴重阻礙。食慾不振、因乳房增大而行動困難以及疼痛也是牛乳腺炎的一些症狀。眼窩凹陷、腸道問題和腹瀉都是酪農罹患牛乳房炎的症狀。加州乳房炎測試（CMT）可以在症狀出現之前的早期階段（亞臨床階段）診斷乳房炎。這是一個簡單的測試，只需少量牛奶即可完成。早期診斷可以防止病情發展到臨床階段，這可能會為酪農帶來高昂的成本。

市場動態

推動全球牛乳腺炎市場擴張的主要因素之一是全球牛乳腺炎盛行率的不斷上升。例如，根據美國國家醫學圖書館和國立衛生研究院2020年 8月發表的一篇論文，在牛群、牛和農場層面，臨床和亞臨床乳房炎的總體盛行率分別為 51.6%（815/1,580）、74.4%（294/395）和 76.6%（118/154）。

本研究的主要特點

• 本報告對全球牛乳腺炎市場進行了詳細分析，並以2024年為基準年，提供預測期（2025-2032年）的市場規模和年複合成長率（CAGR %）。
• 強調了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
• 提供有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 研究報告根據公司亮點、產品系列、關鍵亮點、業務表現和市場策略等參數列出了全球牛乳腺炎市場的主要企業概況。
• 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
• 本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 相關人員將透過用於分析全球牛乳腺炎市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 研究目的與前提

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章 全球牛乳房炎市場洞察

• 促進因素
• 限制因素
• 機會
• 影響分析
• 管道分析
• 市場趨勢
• 主要進展
• 技術進步
• 產品發布/核准
• 收購、合作和交易
• 監管情景
• 流行病學
• PEST分析

第4章 全球牛乳腺炎市場-冠狀病毒（COVID-19）大流行的影響

• 經濟影響
• COVID-19流行病學
• COVID-19對牛乳房炎市場的影響

第5章 2020年至2032年全球牛乳炎市場（依類型）

• 臨床乳腺炎
• 亞臨床性乳腺炎

第6章 2020年至2032年全球牛乳炎市場（依產品）

• 抗生素
• 疫苗
• 止痛藥
• 其他

第7章 全球牛乳腺炎市場（依給藥途徑），2020-2032年

• 乳房內
• 系統性

第8章 全球牛乳腺炎市場（依治療方法），2020-2032年

• 哺乳期
• 乾乳期
• 抗生素
• 乳頭封膠

第9章 2020年至2032年全球牛乳炎市場（依最終用戶）

• 獸醫中心
• 醫院
• 診所
• 其他

第10章 2020-2032年全球牛乳腺炎市場（依地區）

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第11章 競爭格局

• 公司簡介
  • Zoetis
    • 公司亮點
    • 產品系列
    • 主要亮點
    • 財務表現
    • 市場策略
  • Merck & Co., Inc.
    • 公司亮點
    • 產品系列
    • 主要亮點
    • 財務表現
    • 市場策略
  • Boehringer Ingelheim International GmbH
    • 公司亮點
    • 產品系列
    • 主要亮點
    • 財務表現
    • 市場策略
  • Bayer AG
    • 公司亮點
    • 產品系列
    • 主要亮點
    • 財務表現
    • 市場策略
  • Elanco
  • Ceva
  • West Way Health
  • Norbrook
  • DeLaval
  • ImmuCell Corporation
  • Advanced Animal Diagnostics
  • Nimrod Veterinary Products Ltd

第12章 分析師建議

• 命運之輪
• 分析師觀點
• Coherent Opportunity Map

第13章 章節

• 參考
• 調查方法

Global Bovine Mastitis Market is estimated to be valued at USD 1,564.6 Mn in 2025 and is expected to reach USD 2,260.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2032.

Figure. Bovine Mastitis Market Share (%), By Region 2025

Bovine mastitis is characterized by a prolonged and inflammatory response of the udder tissue, as a result of either physical trauma or microorganism-caused illnesses. It is a life threatening mammary gland infection that is most prevalent in dairy cows globally. It's a condition known for causing damage on the dairy industry's profit margin. Mastitis is caused by a huge number of different microorganism species. Viruses, mycoplasmas, fungi, and bacteria are among them. Mastitis manifests itself as a red, hardened lump in the udder. The enlarged mammary gland is extremely hot, and even touching it causes pain and discomfort in animals. To avoid milking, animals will not touch or kick the udder. Blood clots, foul-smelling brown discharge, and milk clots are common in this condition.

Milk production comes to a halt or is seriously hampered as the animal's internal temperature rises. Lack of appetite, mobility issues due to a bloated udder, and soreness are some of the other symptoms of bovine mestitis. Sunken eyes, intestinal problems, and diarrhoea are all symptoms among dairy animals suffering from bovine mestitis. California Mastitis Test (CMT) can diagnose mastitis at an early stage (sub-clinical) before symptoms occur. It is a simple test that may be done on little amount of milk. Early identification aids in preventing the disease from progressing to clinical stages, which would result in significant losses for dairy farmers.

Market Dynamics

One of the primary factors driving the global bovine mastitis market expansion include increasing prevalence of bovine mastitis across the world. For instance, according to an article published by the US National Library of Medicine and National Institutes of Health in August 2020, at the quarter, cow, and farm level, the overall prevalence of clinical and subclinical mastitis was 51.6% (815/1,580), 74.4% (294/395), and 76.6% (118/154), respectively.

Key features of the study:

• This report provides in-depth analysis of the global bovine mastitis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global bovine mastitis market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies.
• Key companies covered as a part of this study include Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global bovine mastitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bovine mastitis market

Detailed Segmentation:

• Global Bovine Mastitis Market, By Type:
  • Clinical Mastitis
  • Sub-clinical Mastitis
• Global Bovine Mastitis Market, By Product:
  • Antibiotics
  • Vaccines
  • Pain Killers
  • Others
• Global Bovine Mastitis Market, By Route of Administration:
  • Intra-mammary
  • Systemic
• Global Bovine Mastitis Market, By Therapy:
  • Lactating Period
  • Dry Period
  • Antibiotics
  • Teat Sealants
• Global Bovine Mastitis Market, By End User:
  • Veterinary Centers
  • Hospital
  • Clinics
  • Others
• Global Bovine Mastitis Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Zoetis
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Bayer AG
  • Elanco
  • Ceva
  • West Way Health
  • Norbrook
  • DeLaval
  • ImmuCell Corporation
  • Advanced Animal Diagnostics
  • Nimrod Veterinary Products Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Product
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Therapy
  • Market Snapshot, By End User
  • Market Snapshot, By Region
  • Market Opportunity Map

3. Global Bovine Mastitis Market Insights

• Drivers
• Restraints
• Opportunity
• Impact Analysis
• Pipeline Analysis
• Market Trends
• Key Developments
• Technological Advancement
• Product Launch/Approvals
• Acquisition, Collaboration & Agreements
• Regulatory Scenario
• Epidemiology
• PEST Analysis

4. Global Bovine Mastitis Market - Impact of Coronavirus (COVID-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact of COVID-19 on Bovine Mastitis Market

5. Global Bovine Mastitis Market, By Type, 2020 - 2032, (US$ Million)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Clinical Mastitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Sub-clinical Mastitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)

6. Global Bovine Mastitis Market, By Product, 2020 - 2032, (US$ Million)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Antibiotics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Pain Killers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)

7. Global Bovine Mastitis Market, By Route of Administration, 2020 - 2032, (US$ Million)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Intra-mammary
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Systemic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million

8. Global Bovine Mastitis Market, By Therapy, 2020 - 2032, (US$ Million)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Lactating Period
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Dry Period
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million
• Antibiotics
• Teat Sealants

9. Global Bovine Mastitis Market, By End User, 2020 - 2032, (US$ Million)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Veterinary Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Hospital
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)

10. Global Bovine Mastitis Market, By Region, 2020 - 2032, (US$ Million)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Region at Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Million)
    • South Africa
    • Central Africa
    • North Africa

11. Competitive Snapshot

• Company Profiles
  • Zoetis
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Elanco
  • Ceva
  • West Way Health
  • Norbrook
  • DeLaval
  • ImmuCell Corporation
  • Advanced Animal Diagnostics
  • Nimrod Veterinary Products Ltd

12. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. Section

• References
• Research Methodology
• About Us and Sales Contact